The Clorox Company $CLX Stake Boosted by Alberta Investment Management Corp

Alberta Investment Management Corp grew its holdings in shares of The Clorox Company (NYSE:CLX) by 1,129.5% during the fourth quarter, Holdings Channel reports. The firm owned 54,100 shares of the company’s stock after acquiring an additional 49,700 shares during the quarter. Alberta Investment Management Corp’s holdings in Clorox were worth $5,455,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of CLX. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox during the 3rd quarter valued at about $25,000. Darwin Wealth Management LLC bought a new position in Clorox in the 2nd quarter worth about $29,000. Vision Financial Markets LLC grew its position in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the last quarter. Ameriflex Group Inc. increased its stake in shares of Clorox by 1,436.8% in the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the period. Finally, Elevated Capital Advisors LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $43,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

NYSE CLX opened at $97.52 on Wednesday. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03. The stock’s 50-day moving average price is $96.26 and its two-hundred day moving average price is $105.05. The company has a market cap of $11.79 billion, a PE ratio of 15.83, a PEG ratio of 0.50 and a beta of 0.56. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same period last year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts predict that The Clorox Company will post 5.61 EPS for the current year.

Insider Activity at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.63% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the topic of several analyst reports. Jefferies Financial Group lowered their target price on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. TD Cowen boosted their price target on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Morgan Stanley lowered their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price objective on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Finally, Zacks Research lowered shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $103.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.